# US 2017/0304205 A1 · Process for preparation of a drug-polymer composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0304205 A1
- Document ID: US20170304205A1
- Status: Published application
- Kind: A1
- Application number: 15/521,827
- Filed: 2015-11-26
- Published: 2017-10-26
- Earliest claimed: 2014-11-30
- Inventors: Kirit Patel
- Web page: https://patentgrep.com/patent/US20170304205A1

## CPC

- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/1682: {Processes}
- A61K 9/2846: {Poly(meth)acrylates}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to an improved active or inactive pharmaceutical ingredient-polymer composition and process of preparation thereof. In particular, the present invention relates to an improved active or inactive pharmaceutical ingredient-polymer composition and process of preparation thereof wherein the monomer encapsulates particles of active or inactive pharmaceutical ingredient at molecular level and with controlled polymerization process the monomer turns into the said polymer coat over the said active or inactive pharmaceutical ingredient that facilitates the disclosed invention to be completed a single step process.

## Claims

### Claim 1

An improved process for preparation of a drug-polymer composition based on monomer and pharmaceutically active or inactive ingredient which produces composite sensitive to pH for the purpose of use in masking taste of bitter drugs, sustained release of API, enteric coating, multiple coating, film coating, pH sensitive coating, protection from outer atmosphere, stability of light sensitive material, stability of moisture sensitive material, smell masking, stability from UV radiation, prevent leaching of the coated material into the vehicle and increasing bioavailability of the API etc. comprising the steps of:
(a) Preparing a uniform blend of the vehicle (water) saturated with salt and surfactants as part A;
(b) Preparing a blend of the desired amount of active drug and thickner and adding it to part A with constant stirring keeping the suspension over a desired period of time in desired temperature as part B;
(c) Preparing a catalyst content with desired amount of DM water as part C;
(d) Adding part C to part B with constant stirring and maintaining the desired temperature as part D;
(e) Separately preparing a homogeneously blend containing desired monomers, from which polymer is formed, and a catalyst and pouring the entire content to the uniformly dispersed part D;
(f) Initiating the reaction in an inert atmosphere for complete polymerization of the monomer, over the subject molecules, in the contents of step (e) by maintaining the desired pH, temperature, pressure and time;
(g) Recovering the polymerized product by filtration and washing repeatedly;
(h) Feeding the contents of step (g) to a spray drier for drying the final product.

### Claim 2 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1, wherein monomers selected are the derivatives of acrylic acid and methacrylic acid.

### Claim 3 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the molecular weight of the polymer ranges from 10,000 to 1,000,000.

### Claim 4 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein ratio of final polymer to subject molecule is in the range of 50:1 to 0.2:1.

### Claim 5 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein catalyst is of a group of redox initiator and/or Oxidizing agent.

### Claim 6 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein subject molecules are organic compounds, inorganic compounds, metal compounds, and Plastics.

### Claim 7 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the subject molecule are organic and inorganic compounds Active Pharmaceutical Ingredients (APIs).

### Claim 8 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 where the process incorporates subject molecule an API which is Water soluble, Water insoluble or partially water soluble.

### Claim 9 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 where in rehology modifiers are added to aid the process.

### Claim 10 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the pH sensitive polymer covering subject molecule can be used for pharmaceutical formulations such as solid, semisolid, and liquid dosage forms.

### Claim 11 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1, wherein the polymer-drug composition so obtained is formulated in a pharmaceutical solid dosage form selected from the group consisting of tablets, capsules, strips, chewable, mouth dissolving, effervescent and dispersible tablets.

### Claim 12 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1, wherein the polymer-drug composition so obtained is formulated in a pharmaceutical liquid dosage form selected from the group consisting of dry syrup and suspension.

### Claim 13 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1, wherein the polymer-drug composition so obtained is formulated in a pharmaceutical semi solid dosage form selected from the group consisting of gel, ointment, cream and paste.

### Claim 14 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the % weight of catalyst to monomers is in the range of 0.1 to 5.

### Claim 15

An improved process for preparation of a drug-polymer composition as claimed in 1 wherein the said process is carried out at a temperature in the range of 20-95° C. and for a period of 1-24 hours.

### Claim 16 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the polymerization time is 1 to 2 hours.

### Claim 17 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the % weight of vehicle to the monomer during the synthesis of the pH sensitive polymer is 10 to 95.

### Claim 18 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the pH range of the reaction is 2 to 10.

### Claim 19 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein salt is selected from edible mineral salt.

### Claim 20 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein Inert gas as claimed in claim 1 is preferably nitrogen gas.

### Claim 21 (depends on 1)

An improved process for preparation of a drug-polymer composition as claimed in claim 1 wherein the drying is carried out at the temperature range of 40 to 200° C.

### Claim 22 (depends on 9)

An improved process for preparation of a drug-polymer composition as claimed in claim 9 wherein said rehology modifier is a viscosity enhancing agent and wetting agent.

### Claim 23 (depends on 22)

The process of claim 22, wherein the A viscosity enhancing agent is selected from the group consisting of acacia, carbomer, carboxy methyl cellulose calcium, carboxy methyl cellulose sodium, hydroxy ethyl cellulose hydroxy propyl cellulose, hydroxy propyl methyl cellulose, methylcellulose, polyvinyl pyrroiidone, powdered cellulose, sodium alginate and tragacanth, guar gum, gumacasia, and xenthan gum.
